Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)

Market Cap	2.85B -36.9%
Revenue (ttm)	1.30B +3.8%
Net Income	11.06M -92.4%
EPS	0.07 -92.3%
Shares Out	167.44M
PE Ratio	254.97
Forward PE	13.80
Dividend	0.25 (1.44%)
Ex-Dividend Date	Jun 3, 2026

Volume	1,338,002
Open	17.45
Previous Close	17.34
Day's Range	16.96 - 17.45
52-Week Range	16.92 - 40.19
Beta	0.59
Analysts	Strong Buy
Price Target	31.00 (+81.93%)
Earnings Date	Aug 10, 2026

About SHA:688687

Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhizin tablets, capsules, and injections; and pirfenidone tablets for mild to moderate idiopathic pulmonary fibrosis. It is also involved in contract manuf...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 617
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688687

Financial Performance

In 2025, SHA:688687's revenue was 1.32 billion, an increase of 7.35% compared to the previous year's 1.23 billion. Earnings were 30.60 million, a decrease of -78.51%.